The cluster signals rising institutional interest ahead of potential pipeline catalysts. However, the concurrent trimming by Jane Street and Millennium suggests short-term hedging or profit-taking. Monitor for upcoming clinical data readouts or partnership announcements that could validate the thesis.
Executive Summary
In Q1 2026, 11 institutional investors accumulated $18.0M in KRRO (net +$16.6M) while 6 reduced holdings by $1.7M. Balyasny Asset Management opened a new $11.8M position (~5.6% of market cap), and AQR Capital Management doubled its stake to $3.0M, suggesting strong conviction in the company's pipeline despite trimming by Millennium and Jane Street.
Key Financial Metrics
Institutional Positions
Net institutional flow: $14.9M
▲ Buyers (11)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Balyasny Asset Management | NEW | — | $11.8M | $11.8M |
| AQR Capital Management | DOUBLED | +558.7% | $3.0M | $2.7M |
| RenTech | ADD | +81.9% | $1.5M | $942.0K |
| JPMorgan | DOUBLED | +2313.7% | $704.0K | $681.0K |
▼ Sellers (6)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Jane Street Group | TRIM | -59.9% | $2.3M | -$1.0M |
| Millennium Management | TRIM | -60.5% | $1.3M | -$570.3K |
| Morgan Stanley | TRIM | -41% | $559.0K | -$93.0K |
Key Facts
- Balyasny Asset Management opened a new $11.8M position (1.04M shares) in Q1 2026
- AQR Capital Management doubled its stake to $3.0M (267.8K shares, +558.7%)
- RenTech added 81.9% to hold $1.5M (136.2K shares)
- Jane Street Group trimmed 59.9% to $1.3M (115.7K shares)
- Millennium Management trimmed 60.5% to $720K (63.6K shares)
- Net institutional accumulation of ~$14.9M across 11 buyers vs 6 sellers
Financial Impact
Net institutional accumulation of $16.6M across 11 buyers versus $1.7M in outflows from 6 sellers. Balyasny's new $11.8M position represents ~5.6% of the $212M market cap.
Risk Factors
- 13F 45-day reporting lag; positions may have been unwound since March 31, 2026
- Pre-revenue biotech with high binary risk from clinical trials
- Insider selling in the past 30 days ($3.9M) may indicate lack of confidence
- Confluence score (19/100) indicates divergence between insider and institutional activity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-KRRO-2026-Q1 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | Insider Buy | $12.46 | awaiting T+1 | — | — |
Oct 22, 2026 4d ago | 8-K | $12.05 $11.98 | ▼ −0.58% | ▼ −0.06% | — |
Oct 16, 2026 10d ago | Press Release | $8.91 $9.44 | ▲ +5.95% | ▲ +5.61% | — |
Oct 5, 2026 21d ago | 8-K | $9.76 $10.49 | ▲ +7.48% | ▲ +7.72% | — |
Oct 5, 2026 21d ago | Press Release | $9.76 $10.49 | ▲ +7.48% | ▲ +7.72% | — |
Sep 15, 2026 5w ago | Insider Cluster | $13.83 $11.80 | ▼ −14.68% | ▼ −15.81% | — |
Aug 13, 2026 10w ago | Insider Cluster | $13.29 $13.28 | ▼ −0.08% | ▲ +0.12% | — |
Aug 6, 2026 11w ago | 8-K | $12.12 $13.25 | ▲ +9.32% | ▲ +8.71% | — |
Jul 9, 2026 15w ago | Institutional Cluster | $14.30 $14.56 | ▲ +1.82% | ▲ +1.39% | — |
Jun 24, 2026 17w ago | Insider Cluster | $12.17 $12.70 | ▼ −4.36% | ▼ −5.08% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers